Addus HomeCare Corporation (ADUS) delivered first-quarter 2026 earnings per share (EPS) of $1.62, exceeding analyst consensus of $1.55 by $0.07. However, revenue reached $336.6 million, falling slightly short of expectations. Despite the EPS beat, shares plunged 3.12% to $97 in extended trading, touching a 52-week low.
Key Financial Highlights
The EPS upside reflects robust operational performance amid challenges. Revenue missed forecasts by a narrow margin, yet personal care and hospice segments posted 7.7% year-over-year growth. Adjusted EBITDA climbed 9.7% to $44.5 million compared to the prior-year quarter.
- Revenue: $336.6 million, down 0.77% from consensus of $336.42 million; up 7.7% year-over-year.
- Diluted EPS: $1.62, up 14.1% year-over-year.
- Adjusted EBITDA: $44.5 million, up 9.7% from Q1 2025.
- Operating revenue: $52.4 million, surging 177%.
Guidance and Outlook
Executives maintained full-year 2026 guidance, projecting EPS growth of 14.1% and revenue near $1.497 billion. Q2 and Q4 EPS estimates stand at $1.70 and $1.87, respectively. Analysts view the outlook as positive, signaling sustained momentum in home health services.
CEO Commentary
CEO Dirk Allison highlighted resilient operating trends, stating, “Recent hurricanes and Medicaid changes have influenced overall results, yet they underscore our market share gains in home health.”
Market Reaction and Risks
Investors focused on the revenue shortfall, driving the post-earnings drop. The decline aligns with broader concerns over Medicare Advantage shifts and external factors like weather events. Management reassured stakeholders during the Q&A that growth in key segments offsets these pressures.
Potential headwinds include currency fluctuations, regulatory changes in Medicare, and macroeconomic impacts on Medicaid reimbursements. Addus continues expanding its store network to capture demand in the home healthcare sector.
